Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
|Active Ingredient:||Paracetamol 500mg|
|New Zealand Sponsor:||PSM Healthcare Limited trading as API Consumer Brands|
|Manufacturer:||Sterling Healthcare Limited, Pune, India|
|Note: This consent is given subject to the following conditions:
|Note: This consent is valid for two years from the date of publication of this notice.|
Dated this 31st day of May 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).